Job objective
Environment
Internal and external interactions i.e.: with other departments/divisions, international scope,
providers, customers)
Internal: Operations, Quality, Supply chain and Logistics.
External: Third parties' warehouse, Suppliers.
Key responsibility
Receive, store, and issue supplies (donation-related supplies, stationary, etc.).
Compiles records of supplies and out, verify that supplies received are listed on requisitions and
invoices.
Keep accurate stock control records.
Maintain the store and records in a neat and orderly manner.
Perform other related duties as assigned for the purpose of ensuring the efficient and effective
functioning of the stock control processes.
Academic experience required
High School diploma or equivalent combination of education and experience.
Professional experience required
Preferred, a minimum of 1 years of related experience.
Computing skills
Experience in Microsoft Office applications.
Experience in ERP systems.
Personal skills
Strong communication skills.
Detail oriented.
Able to organize matters & multi-task.
Work cooperatively with others.
Languages
Written and spoken English and Arabic.
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.
